Judge Voids HHS Policy Limiting Hospital Discount Drug Purchases
Bloomberg Law covers a federal court ruling vacating a 2013 Health Resources and Services Administration (HRSA) policy that restricted hospitals from purchasing drugs through both the 340B discount program and group purchasing organizations. The decision, issued by the U.S. District Court for the District of Columbia, found the policy lacked sufficient justification and ruled in favor of Premier Inc., which challenged the restriction. The ruling could impact how hospitals manage drug purchasing strategies within the 340B program.
